Zugck C, Müller A, Helms T M, Wildau H J, Becks T, Hacker J, Haag S, Goldhagen K, Schwab J O
Abteilung für Kardiologie, Angiologie und Pulmologie, Universitätsklinikum Heidelberg.
Dtsch Med Wochenschr. 2010 Apr;135(13):633-8. doi: 10.1055/s-0030-1251912. Epub 2010 Mar 23.
Patients with congestive heart failure represent a significant amount of the total annual cost of the health care system. Because of a lack of studies on the economic health cost of the related health care, including all cost generating factors, we analysed in detail characteristics of these patients and the costs created by their care.
Data were retrieved from the German Bureau of Health Statistics for the year 2002 relating to congestive heart failure (Code I50) including other factors (e. g. co-morbidities, ambulatory and hospital care and choice of the doctor). The data were from more than 2 million patients, from 350 insurance companies, the Federal Employees Insurance and the German Institute for Medical Informatics and Documentation. A total of 86 193 patients with congestive heart failure had been recorded.
More women than men were recorded as having congestive heart failure (66 vs. 34 %). The various health insurance companies paid 2.3 times more for patients with than without congestive heart failure. Nearly three quarters of the cost for these patients (72 %) resulted from in-patient care. Moreover, costs for drugs were three times higher (1073 Euro vs. 366 Euro).
This analysis clearly demonstrates the increased costs incurred for patients with congestive heart failure. It should serve as a reference base for better assessing future innovations, such as telemedicine, for their effects in different sectors of health care.
充血性心力衰竭患者占医疗保健系统年度总费用的很大一部分。由于缺乏对包括所有成本产生因素在内的相关医疗保健经济健康成本的研究，我们详细分析了这些患者的特征及其护理产生的成本。
从德国卫生统计局获取了2002年与充血性心力衰竭（代码I50）相关的数据，包括其他因素（如合并症、门诊和住院护理以及医生选择）。数据来自超过200万患者、350家保险公司、联邦雇员保险以及德国医学信息与文献研究所。总共记录了86193例充血性心力衰竭患者。
记录显示患有充血性心力衰竭的女性多于男性（66%对34%）。各健康保险公司为患有充血性心力衰竭的患者支付的费用是未患患者的2.3倍。这些患者近四分之三的费用（72%）来自住院护理。此外，药物费用高出三倍（1073欧元对366欧元）。
该分析清楚地表明了充血性心力衰竭患者产生的费用增加。它应作为一个参考基础，以便更好地评估未来的创新，如远程医疗，在医疗保健不同领域的效果。
